Galen's venous artery disease is a suspected disease in the field of blood tumors, with complex clinical outcomes that often involve multi-systemic strain. Early identification and standardized clinical care are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical outcomes, imaging, laboratory testing and pathological activation.
The platform can help to match the needs of a team of nationally and internationally authoritative experts to provide accurate diagnosis and treatment programs. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many previously difficult-to-treat blood tumour diseases have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to the timely schedule according to changes in the condition.
Multidisciplinary collaboration (MDT) is particularly important for the integrated management of Galen's vascular tumors. 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.